About Lineage Therapeutics
Lineage Therapeutics is a Healthcare company based in Horsham (United States) founded in 2015, and was acquired by Impax Laboratories in March 2015. Generic dosage forms for pharmaceuticals are manufactured by Lineage Therapeutics. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Lineage Therapeutics was established in 2015 and is based in Horsham, United States. Operations focus on the pharmaceutical sector, where generic drugs are produced in various forms. Key offerings include epinephrine auto-injectable for emergency allergic reactions, dextroamphetamine sulfate extended-release capsules for narcolepsy and ADHD treatment, and hydrocortisone tablets. Manufacturing emphasizes standard dosage formats for these medications.
- Headquarters Horsham, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lineagetherapeutics.com
- Social LinkedIn
- Acquired by Impax Laboratories (Mar 2015)
- Investors
- Acquired byImpax Laboratories
(Mar 2015)
Investors in Lineage Therapeutics
Lineage Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Impax Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Generic versions of brand-name medications are developed and manufactured. | 1999 | impaxlabs.com | Hayward, United States |
Investor details for Lineage Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Lineage Therapeutics
2 dated milestones of Lineage Therapeutics, from founding to its latest funding, stage changes and deals.
- Founded Lineage Therapeutics is founded.
- Exit Acquired by Impax Laboratories.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Lineage Therapeutics (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lineage Therapeutics
Lineage Therapeutics was founded in 2015.
Lineage Therapeutics is headquartered in Horsham, United States. It is registered at Horsham, Pennsylvania, United States.
Lineage Therapeutics was established in 2015 and is based in Horsham, United States. Operations focus on the pharmaceutical sector, where generic drugs are produced in various forms. Key offerings include epinephrine auto-injectable for emergency allergic reactions, dextroamphetamine sulfate extended-release capsules for narcolepsy and ADHD treatment, and hydrocortisone tablets. Manufacturing emphasizes standard dosage formats for these medications.
Lineage Therapeutics has 1 investor. Key investors include Impax Laboratories.
Yes. Lineage Therapeutics was acquired by Impax Laboratories in March 2015.